Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-01 · accession 0001415889-23-013042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-09-06 | 2023-09-01+ | KNSA | Ragosa Mark | CFO | F - Tax | $17.76 | -1,338 | 15.6K | -8% | -$23.8K |
| DM | 2023-09-06 | 2023-09-01+ | KNSA | Ragosa Mark | CFO | M - OptEx | — | +4,556 | 16.2K | +39% | — |
| DM | 2023-09-06 | 2023-09-01+ | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -4,556 | 3,722 | -55% | $0 |
| DM | 2023-09-06 | 2023-09-01 | KNSA | Ragosa Mark | CFO | A - Grant | $0.00 | +49.0K | 7,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-09-01 | F | D | 791 | $17.76 | 14,318 | D | — | — | |
| 2 | Common | Class A Common Share | 2023-09-01 | M | A | 2,695 | — | 15,109 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 3 | Common | Class A Common Share | 2023-09-02 | F | D | 547 | $17.76 | 15,632 | D | — | — | |
| 4 | Common | Class A Common Share | 2023-09-02 | M | A | 1,861 | — | 16,179 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 5 | Derivative | Restricted Share Unit | 2023-09-01 | M | D | 2,695 | $0.00 | 8,082 | D | — · — to — | 2,695 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2022. |
| 6 | Derivative | Restricted Share Unit | 2023-09-02 | M | D | 1,861 | $0.00 | 3,722 | D | — · — to — | 1,861 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F5) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 2, 2021. |
| 7 | Derivative | Share Option | 2023-09-01 | A | A | 42,050 | $0.00 | 42,050 | D | $17.76 · — to — | 42,050 Class A Common Share | (F4) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023. |
| 8 | Derivative | Restricted Share Unit | 2023-09-01 | A | A | 7,000 | $0.00 | 7,000 | D | — · — to 2033-08-31 | 7,000 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F3) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2023. |